Last reviewed · How we verify
NCT07218042: SPEED NEEDLE
Study of Procedural Efficiency in EBUS With Dual Versus Single NEEDLEs: Evaluating the Value of a Second Needle in EBUS as it Pertains to Economic and Environmental Impact
NA trial testing We randomized patients to the two arms above; there was no specific intervention performed other than randomizing patients to one or two needles. in Mediastinal and Hilar Lymphadenopathy in 126 participants. Participants enrolled and being followed up; not accepting new ones.
1 August 2025
Quick facts
| Lead sponsor | Christopher Kapp |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | diagnostic |
| Enrollment | 126 |
| Start date | 2 February 2024 |
| Primary completion | 1 August 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- We randomized patients to the two arms above; there was no specific intervention performed other than randomizing patients to one or two needles.
Conditions studied
- Mediastinal and Hilar Lymphadenopathy — all drugs for Mediastinal and Hilar Lymphadenopathy →
Sponsor
Christopher Kapp
Who can join
18 and older, any sex, with Mediastinal and Hilar Lymphadenopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Currently, the EBUS bronchoscopy procedure uses either one or two needles to perform the biopsy of the lymph node based on physician preference. We want to determine the optimal number of needles to use for future EBUS bronchoscopy procedures like the one you are scheduled to have for your care and investigate the economic and environmental impact and time involved in using one versus two needles.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07218042
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07218042 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Christopher Kapp
- Last refreshed: 20 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07218042.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing